These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 15634918
1. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR. J Immunol; 2005 Jan 15; 174(2):953-61. PubMed ID: 15634918 [Abstract] [Full Text] [Related]
2. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. Hau HH, Walsh RJ, Ogilvie RL, Williams DA, Reilly CS, Bohjanen PR. J Cell Biochem; 2007 Apr 15; 100(6):1477-92. PubMed ID: 17133347 [Abstract] [Full Text] [Related]
3. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. Brooks SA, Connolly JE, Rigby WF. J Immunol; 2004 Jun 15; 172(12):7263-71. PubMed ID: 15187101 [Abstract] [Full Text] [Related]
4. Tristetraprolin mediates interferon-gamma mRNA decay. Ogilvie RL, Sternjohn JR, Rattenbacher B, Vlasova IA, Williams DA, Hau HH, Blackshear PJ, Bohjanen PR. J Biol Chem; 2009 Apr 24; 284(17):11216-23. PubMed ID: 19258311 [Abstract] [Full Text] [Related]
5. Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications. Cao H. Biochemistry; 2004 Nov 02; 43(43):13724-38. PubMed ID: 15504035 [Abstract] [Full Text] [Related]
6. Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. Rigby WF, Roy K, Collins J, Rigby S, Connolly JE, Bloch DB, Brooks SA. J Immunol; 2005 Jun 15; 174(12):7883-93. PubMed ID: 15944294 [Abstract] [Full Text] [Related]
7. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli. Qiu LQ, Lai WS, Bradbury A, Zeldin DC, Blackshear PJ. J Leukoc Biol; 2015 Apr 15; 97(4):723-36. PubMed ID: 25657290 [Abstract] [Full Text] [Related]
10. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Stoecklin G, Gross B, Ming XF, Moroni C. Oncogene; 2003 Jun 05; 22(23):3554-61. PubMed ID: 12789264 [Abstract] [Full Text] [Related]
11. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase. Sanduja S, Kaza V, Dixon DA. Aging (Albany NY); 2009 Sep 10; 1(9):803-17. PubMed ID: 20157568 [Abstract] [Full Text] [Related]
12. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. Mol Cell Biol; 2006 Mar 10; 26(6):2399-407. PubMed ID: 16508014 [Abstract] [Full Text] [Related]
13. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. Mol Cell Biol; 2001 Oct 10; 21(19):6461-9. PubMed ID: 11533235 [Abstract] [Full Text] [Related]
14. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. Yu H, Stasinopoulos S, Leedman P, Medcalf RL. J Biol Chem; 2003 Apr 18; 278(16):13912-8. PubMed ID: 12578825 [Abstract] [Full Text] [Related]
15. Tristetraprolin down-regulates IL-17 through mRNA destabilization. Lee HH, Yoon NA, Vo MT, Kim CW, Woo JM, Cha HJ, Cho YW, Lee BJ, Cho WJ, Park JW. FEBS Lett; 2012 Jan 02; 586(1):41-6. PubMed ID: 22138182 [Abstract] [Full Text] [Related]
16. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, Takatori H, Saito Y, Iwamoto I. J Exp Med; 2003 Dec 01; 198(11):1717-27. PubMed ID: 14638848 [Abstract] [Full Text] [Related]
17. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. Tchen CR, Brook M, Saklatvala J, Clark AR. J Biol Chem; 2004 Jul 30; 279(31):32393-400. PubMed ID: 15187092 [Abstract] [Full Text] [Related]
18. Coordinated expression of tristetraprolin post-transcriptionally attenuates mitogenic induction of the oncogenic Ser/Thr kinase Pim-1. Mahat DB, Brennan-Laun SE, Fialcowitz-White EJ, Kishor A, Ross CR, Pozharskaya T, Rawn JD, Blackshear PJ, Hassel BA, Wilson GM. PLoS One; 2012 Jul 30; 7(3):e33194. PubMed ID: 22413002 [Abstract] [Full Text] [Related]
19. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA. Dai XY, Cai Y, Sun W, Ding Y, Wang W, Kong W, Tang C, Zhu Y, Xu MJ, Wang X. Cardiovasc Res; 2014 Feb 01; 101(2):297-305. PubMed ID: 24253523 [Abstract] [Full Text] [Related]
20. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P. EMBO J; 2004 Mar 24; 23(6):1313-24. PubMed ID: 15014438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]